The Science of Decision Making: Connecting People and Policy

描述（由申请人提供）：格鲁吉亚州立大学，沿着其主要合作伙伴，伊利诺伊大学，芝加哥和RTI国际，正在申请被指定为FDA烟草监管科学中心。我们的重点将放在监管科学的一个特别重要但经常被忽视的方面：对有助于烟草产品使用决策的人为和经济因素的理解。 我们的提案题为“决策的科学：连接人与政策”，将使用多学科视角，整合来自社会科学和公共卫生的学科。通过三个相互关联的研究项目，人类的经济行为，消费者对烟草营销的反应，以及个人对使用烟草产品风险的感知，将被检查。 我们将使用最先进的实验、虚拟和在线调查研究方法，进一步了解促使个人决定使用烟草产品的因素。对这些结果的分析和解释将有助于FDA了解监管行动，这些行动可以改善准确的风险认知，并影响使用烟草产品的决定，特别是新产品和新兴产品。Frank Chaloupka将与一个经济学家团队合作，他们的工作旨在提供新的证据，为FDA对未来拟议规则的经济影响评估提供信息。为了进一步加深FDA对烟草营销的理解，Matthew Farelly和James Nonnemaker将利用视觉沉浸方法来研究购买点环境以及如何改变这种环境以影响消费者行为。第三个项目侧重于对替代和新型烟草产品进行消费者行为、风险认知和媒体研究。它将由Michael Eriksen领导，他还将担任总项目总监。该研究小组将进行调查和定性研究，监测烟草制品的使用和对烟草制品的看法，特别强调新型和替代烟草制品。我们会成立三个核心小组（行政、培训及教育、发展及先导研究），以支援计划，并促进各小组之间的交流和分享。 相关性：烟草使用既是一种主要的可预防的死亡原因，也是一种基本的非理性行为。该项目提议进行一系列调查和实验，以更好地了解当前和潜在烟草使用者的经济、营销和风险认知，并为FDA提供科学证据，以协助建立促进公共健康的监管框架。

DESCRIPTION (provided by applicant): Georgia State University, along with its major partners, the University of Illinois, Chicago and RTI International, are applying to be designated as an FDA Tobacco Center of Regulatory Science. Our focus will be on a particularly important and often overlooked aspect of regulatory science: the understanding of the human and economic factors that contribute to decision-making regarding the use of tobacco products. Our proposal, entitled "The Science of Decision Making: Connecting People and Policy" will use a multi- disciplinary perspective integrating disciplines from social sciences and public health. Through three inter- related research projects, human economic behavior, consumer reaction to tobacco marketing, and individual perception of risk of using tobacco products, will be examined. We will use state-of-the-art experimental, virtual and online survey research methodology to further the understanding of factors that contribute to an individual's decision to use tobacco products. Analysis and interpretation of these results will help inform the FDA on regulatory actions that could improve accurate risk perceptions and influence the decision to use tobacco products, particularly new and emerging products. Frank Chaloupka will work with a team of economists whose work will aim to produce new evidence to inform the FDA's economic impact assessments of future proposed rules. To further the FDA's understanding of tobacco marketing, Matthew Farelly and James Nonnemaker will utilize visual immersion methodology to examine the point of purchase environment and how it can be changed to influence consumer behavior. The third project focuses on conducting consumer behavior, risk perception and media research on alternate and novel tobacco products. It will be headed by Michael Eriksen, who will also serve as the overall Program Director. This research team will conduct survey and qualitative research that will monitor the use of and perceptions about tobacco products, with special emphasis on novel and alternative tobacco products. Three core teams (Administrative, Training & Education, Developmental & Pilot Research) will be established to support the projects and facilitate interaction and sharing amongst them. RELEVANCE: Tobacco use is both a leading preventable cause of death and fundamentally, an irrational behavior. This project proposes to conduct a series of surveys and experiments to better understand the economic, marketing and risk perceptions of current and potential tobacco users and provide FDA the scientific evidence that will assist in establishing a regulatory framework that will advance public health.